BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2003
View Archived Issues
Sertraline reported to improve major depression in patients with AD
Read More
Sepracor updates status of key clinical development programs
Read More
New factor XIIIa inhibitors prepared and tested at Curacyte
Read More
Antimitotic drugs in early development at Pfizer
Read More
Sumitomo presents new 5-HT reuptake inhibitors/5-HT1A agonists
Read More
Novel peripheral BZ receptor ligands with neurotrophic activity claimed by Sanofi-Synthelabo
Read More
SCRAS scientists design new inhibitors of protein phosphatases
Read More
Radiolabeled Ab fragments and their use as angiogenesis markers in cancer diagnosis and treatment
Read More
Neurogen updates pipeline status
Read More
Abbott and LigoCyte enter collaboration for antiinflammatory monoclonal antibody
Read More
Preliminary PRIMO-CABG results reported
Read More
Allos Therapeutics commences rolling NDA submission for RSR-13
Read More
Norak acquires ChemFolio compound library
Read More
ISTA files second Vitrase NDA
Read More
Collaborative Study Group to conduct KRX-101 phase II/III program
Read More
Prana selects PBT-2 for development for Alzheimer's disease
Read More
New phase II trial evaluates NicVAX in smokers
Read More
aaiPharma and CIMA to merge
Read More
Small-molecule inhibitors of c-Met pursued at Sugen as potential anticancer agents
Read More
Lilly to use Serenex chemoproteomics technologies for screening
Read More
Bimosiamose decreases LAR in asthmatics following allergen challenge
Read More
Genome Therapeutics expands ramoplanin development program
Read More
Design of dual Src/Abl tyrosine kinase inhibitors with antitumor and antimetastatic activity
Read More
New agent with dual radiosensitizing and cytotoxic activity
Read More